You are here: Industry Insights > API

News List

Evolving World of Pharma: Supply Chain Disruption Going Viral Sarah Harding
April 02, 2020
It has been estimated that as much as 80% of APIs used by pharma manufacturers in the US originate from China or India.
Chinese API Industry’s Position Becoming Prominent under the Global Anti-epidemic Background PharmaSources/Xiaoyaowan
April 03, 2020
The China Pharmaceutical Industry Association (CPIA) released the Notice on Doing a Good Job in Active Pharmaceutical Ingredient and Intermediate Production and Supply provides the “draft list of priority products subject to shortage monitoring due to pro
Customers in multiple countries want to cooperate with us En-CPhI.CN
October 08, 2019
At this year's CPhI China 2019 exhibition, Chongqing Asincan Biotech Co.,Ltd has brought new and characteristic products.
SeraNovo and AstraZeneca to Collaborate on Research Projects PharmaSources
May 16, 2023
SeraNovo is pleased to announce the closing of a multi-compound deal with AstraZeneca.SeraNovo (Leiden, The Netherlands) is pleased to announce the closing of a multi-compound deal with AstraZeneca.
Piramal spends £55m to bolster its UK manufacturing presence CPhIonline
February 10, 2022
The investment covers two expansions to accommodate several pipeline products moving to commercial scale.
Supply chain automation and traceability in lifesciences sector expresspharma
December 02, 2021
Global supply chains are complex and interconnected as manufacturers are dependent on other nations, especially developing countries, for procurement of active components, API or any other raw materials that go into the manufacturing of drugs...
API supply chain needs to address future challenges arising from China situation: CPhI Worldwide panel CPhIonline
October 27, 2021
The COVID-19 pandemic has exposed weaknesses in the complex supply chain for active pharmaceutical ingredients (APIs) and the sector needs to address the challenges of rising production costs in China...
UK Regulators Recall Batches of “Sartan” Drug for Azido Impurities americanpharmaceuticalreview
August 13, 2021
The UK Medicines and Healthcare products Agency (MHRA) is recalling 25 batches of irbesartan-containing products as a precautionary measure due to contamination with an azido impurity, which the agency says has mutagenic potential.
India lags behind in terms of commercially-oriented innovation, R&D and discovery of drug modules expresspharma
August 13, 2021
Established in 1977 by G V Masurkar, ENTOD is one of the fastest growing pharmaceutical companies in the Ophthalmic ENT segment in different markets around the world, with over forty years of specialised expertise in product development and manufacturing.
Almac, PILA PHARMA Enter API Manufacturing Pact contractpharma
August 12, 2021
Almac will manufacture XEN-D0501, a highly selective and very potent small molecule TRPV1 antagonist for ongoing type 2 diabetes clinical studies.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page